Results 131 to 140 of about 3,362,872 (199)

HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells. [PDF]

J Cell Physiol, 2018
You H, Kong F, Zhou K, Wei X, Hu L, Hu W, Luo W, Kou Y, Liu X, Chen X, Zheng K, Tang R.   +11 more
europepmc   +1 more source

Natural products targeting hepatitis B virus X protein and HBx-associated pathways in HBV-related hepatocellular carcinoma: mechanisms and therapeutic potential. [PDF]

Pharm Biol
Nguyen TNA, Thongsri P, Pewkliang Y, Chomnawang MT, Thirapanmethee K, Sa-Ngiamsuntorn K.   +5 more
europepmc   +1 more source

The PTM switches of HBx: Master regulators of HBV infection and liver oncogenesis. [PDF]

Virus Res
Ye Z, Ma M, Yu D, Hu Y, Liu Y, Zhao J, Su Z, Zhao X.   +7 more
europepmc   +1 more source

Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets. [PDF]

Expert Opin Drug Discov
Chen J, Quist T, Fang R, Nguyen HT, Pandelia ME.   +4 more
europepmc   +1 more source

Virome-Associated Hepatitis B Protein X Drives Epithelial-Mesenchymal Plasticity and Enhances Colorectal Carcinogenesis. [PDF]

Cell Mol Gastroenterol Hepatol
Facoetti A, Cagliani S, Massimino L, Nicolò S, Palmieri O, HBx-CRC Study Group, Ungaro F.   +6 more
europepmc   +1 more source

HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma. [PDF]

Cancer Sci, 2017
Gao Q, Wang K, Chen K, Liang L, Zheng Y, Zhang Y, Xiang J, Tang N.   +7 more
europepmc   +1 more source

Targeting Mitochondrial PD-L1 O-GlcNAcylation to Sensitize HBV-Related HCC to Immunotherapy: Modulating Golgi-mitochondrial Crosstalk and mTOR/PGC-1α-Driven Mitochondrial Biogenesis to Overcome Resistance. [PDF]

Int J Biol Sci
Du ZB, Ma XY, Zhang HY, Lei JM, He XX, Xu WQ, Zhou WD, Xia XG, Zhuang AB, Chen XX, Yao YL, Li WG, Lin YC, Lin ZN.   +13 more
europepmc   +1 more source

Hepatitis B virus promotes hepatocellular carcinogenesis by activating IL-6-dependent tumor-macrophage crosstalk and M2-like macrophage polarization. [PDF]

J Biol Chem
Liu Y, Cao X, Yang B, Zheng H, Zhong H, Tao D, Li M, Luo Z.   +7 more
europepmc   +1 more source

Combined C-terminal truncation and point mutations in HBx in genotype D1 HBV-associated hepatocellular carcinoma. [PDF]

Infect Agent Cancer
Yu M, Alkhawaja AS, Mollaei H, Fazila Z, Jasur R, Roudbaneh EM, Roudbaneh EM, Jalali KM.   +7 more
europepmc   +1 more source

Molecular Basis and Clinical Significance of the High-risk Phenotype of Hepatitis B Virus Genotype C. [PDF]

J Clin Transl Hepatol
Huang C, Liu Z, Zhang J, Shen T, Sang L.
europepmc   +1 more source